Design & development of PIM-1 Kinase-specific inhibitors as preclinical lead for the Prostate cancer therapy | India Science, Technology & Innovation - ISTI Portal

×

Accessibility Controls

Design & development of PIM-1 Kinase-specific inhibitors as preclinical lead for the Prostate cancer therapy

Implementing Organization

Jamia Millia Islamia

Principal Investigator

Dr. M.I. Hassan Jamia Millia Islamia C.I.R.B.S. Delhi

Related Research

Funding Organization

Funding Organization

Council of Scientific and Industrial Research (CSIR)

Quick Information

Area of Research

Medical Sciences

Focus Area

General Scheme (GS)

Start Date

2020

End Date

2021

Duration

36

Status

Completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

Publications

00

No. of Patents

Filed : 00

Grant : 00

Latest Updates

Loading…